摘要
目的 观察线粒体融合素(mfn)-2对裸鼠成瘤性及增殖瘤的增殖、转移的影响。方法裸鼠共分为3组:实验组、空载体对照组、空白对照组,分别将3组MCF-7细胞异种移植到无胸腺小鼠体内,建立裸鼠人乳腺癌移植瘤模型,比较3组裸鼠之间肿瘤的大小和重量,逆转录-聚合酶链反应(RT—PCR)检测3组肿瘤组织mfn2的表达,免疫组织化学半定量检测核增殖抗原(Ki-67)、血管内皮生长因子(VEGF)的表达。结果实验组、空载体对照组、空白对照组3组肿瘤瘤体质量(单位:g)分别为1.78±0.13、2.84±0.16、2.77±0.12,实验组裸鼠肿瘤重量明显低于对照组(P〈0.05),实验组瘤体的体积与两对照组比较差异有统计学意义(P〈0.05),实验组mfn2基因高表达(P〈0.05),两对照组低表达,两对照组之间差异无统计学意义(P〉0.05),实验组与两对照组比较,实验组Ki-67的表达升高,而VEGF的表达明显降低(P〈0.05)。结论mfn2基因可明显抑制人乳腺癌成瘤,对人乳腺癌裸鼠移植成瘤后的增殖和转移能力有影响。
Objective To investigate the effects of Mitofusin-2 gene (mfn2) on the neoplasia, proliferation and metastasis of Human breast carcinoma cells in vivo. Methods The cells were divided into three groups:non-transfection group as negative control group, pEGFP-C2 transfection group as experimental control group, and pEGFPmfn2 transfection group as experimental group. Fifteen nude mice were randomly divided into 3 groups:the experimental group, the experimental control group, and the negative groups that were heterografted with three groups' cells respectively. The expression of mfn2 was detected by RT-PCR in tumor tissues. The expression of Ki-67 and VEGF was detected by immunohistochemistry. Results The tumor weight in negative control, experimental control and experimental groups was (2.77 ± 0. 12), (2.84 ±0. 16) and (1.78± 0. 13 ) g, respectively. The tumor weight in experimental group was significantly lighter than in two control groups ( P 〈 0.05 ). The tumor volume in experimental group was markedly less than in experimental control and negative control groups (P 〈 0.05 ). The expression of mfn2 in experimental group was higher than in experimental control and negative control groups (P 〈 0.05 ). The expression of Ki-67 in experimental group was higher than in experimental control and negative control groups (P 〈 0.05), but the expression of VEGF in experimental group was lower than in experimental control and negative control groups ( P 〈 0.05 ). Conclusion Exogenous mfn2 can strongly inhibit proliferation and metastatic progression of breast carcinoma MCF-7 in xenograft implantation model.
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2009年第4期419-421,545,共4页
Chinese Journal of Experimental Surgery
基金
卫生部临床学科重点项目:“临床肿瘤的细胞周期诊断与分析(三)”
国家重点基础研究发展规划(973)项目(2004CB518705)